Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.003
Sell
RSI(14)
44.415
Neutral
STOCH(KDJ)(9,3,3)
28.936
Neutral
ATR(14)
0.041
Low Volatility
CCI(14)
-86.132
Neutral
Williams %R
76.761
Sell
TRIX(12,20)
-0.185
Sell
StochRSI(14)
21.989
Sell
Search
Envoy Medical Inc
COCHAdd to Watchlist
0.647USD
-0.017-2.53%
Close 05/15, 16:00（ET）Quotes delayed by 15 min
49.74MMarket Cap
LossP/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of Envoy Medical Inc
Currency: USD Updated: 2026-05-15Key Insights
Envoy Medical Inc's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is significant.Its valuation is considered fairly valued, ranking 134 out of 206 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 6.00.In the medium term, the stock price is expected to trend down.The company has shown weak stock market performance over the past month, in line with its weak fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Envoy Medical Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Negative
Envoy Medical Inc Highlights
StrengthsRisks
Envoy Medical, Inc. is a hearing health company. The Company is engaged in providing medical technologies across the hearing loss spectrum, all designed to shift the paradigm within the hearing industry and bring both providers and patients the hearing devices they require. Its hearing solutions include hearing aids, middle ear implants, bone conduction devices and cochlear implants. The bone conduction hearing device has two components: an external component and a surgically implanted fixture placed in the bone behind the ear. Its bone conduction hearing device offers amplification without ear mold in the ear. Its hearing aids are devices that amplify sound for those with mild to moderate hearing loss. Its Esteem is a fully implanted active middle ear implant designed to improve the hearing of adults diagnosed with moderate to severe sensorineural hearing loss. Cochlear implants are a solution for people with moderate-to-profound sensorineural hearing loss.
Growing
The company is in a growing phase, with the latest annual income totaling USD 241.00K.
Overvalued
The company’s latest PE is -0.63, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 1.86M shares, decreasing 28.35% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 0.00 shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.79.
Analyst Rating
Based on
1
analysts
Buy
Current Rating
6.000
Target Price
+812.13%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Financial Health
Currency: USD Updated: 2026-05-15The current financial score of Envoy Medical Inc is 5.39, ranking 196 out of 206 in the Healthcare Equipment & Supplies industry. Its financial status is weak, and its operating efficiency is low. Its latest quarterly revenue reached 39.00K, representing a year-over-year decrease of 15.22%, while its net profit experienced a year-over-year decrease of 8.58%.
Score
Financials
5.66
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
7.12
Operational Efficiency
2.84
Growth Potential
4.24
Shareholder Returns
7.08
Envoy Medical Inc's Company Valuation
Currency: USD Updated: 2026-05-15The current valuation score of Envoy Medical Inc is 8.74, ranking 10 out of 206 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -0.63, which is -100.00% below the recent high of 0.00 and -1858.01% above the recent low of -12.39.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 134/206
Relevant data have not been disclosed by the company yet.
Earnings Forecast
Currency: USD Updated: 2026-05-15The current earnings forecast score of Envoy Medical Inc is 8.00, ranking 66 out of 206 in the Healthcare Equipment & Supplies industry. The average price target is 8.25, with a high of 9.50 and a low of 7.00.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Analyst Rating
Based on
1
analysts
Buy
Current Rating
6.000
Target Price
+803.89%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
93
Total
4
Median
7
Average
Company name
Ratings
Analysts
Envoy Medical Inc
COCH
1
Boston Scientific Corp
BSX
37
Edwards Lifesciences Corp
EW
35
Intuitive Surgical Inc
ISRG
35
Veeva Systems Inc
VEEV
30
Thermo Fisher Scientific Inc
TMO
30
1
2
3
...
19
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2026-05-15The current price momentum score of Envoy Medical Inc is 2.76, ranking 199 out of 206 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 0.71 and the support level at 0.60, making it suitable for range-bound swing trading.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
0.659
Sell
MA10
0.667
Sell
MA20
0.673
Sell
MA50
0.698
Sell
MA100
0.681
Sell
MA200
0.840
Sell
Institutional Confidence
Currency: USD Updated: 2026-05-15The current institutional shareholding score of Envoy Medical Inc is 3.00, ranking 133 out of 206 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 2.42%, representing a quarter-over-quarter decrease of 75.32%. The largest institutional shareholder is The Vanguard, holding a total of 0.00 shares, representing 0.00% of shares outstanding, with 100.00% decrease in holdings.
Score
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Risk Assessment
Currency: USD Updated: 2026-05-15The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Envoy Medical Inc is 1.58, ranking 182 out of 206 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.89. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. with an industry-leading ESG disclosure.
Score
Beta vs S&P 500 index
1.89
VaR
--
240-Day Maximum Drawdown
+77.06%
240-Day Volatility
+145.54%
Return
Best Daily Return
60 days
+13.94%
120 days
+69.20%
5 years
--
Worst Daily Return
60 days
-9.40%
120 days
-20.52%
5 years
--
Sharpe Ratio
60 days
-0.57
120 days
+0.38
5 years
--
Risk Assessment
Maximum Drawdown
240 days
+77.06%
3 years
+100.00%
5 years
+100.00%
Return-to-Drawdown Ratio
240 days
-0.74
3 years
--
5 years
-0.19
Skewness
240 days
+5.45
3 years
+7.34
5 years
--
Volatility
Realised Volatility
240 days
+145.54%
5 years
--
Standardised True Range
240 days
+13.16%
5 years
+148.49%
Downside Risk-Adjusted Return
120 days
+90.65%
240 days
+90.65%
Maximum Daily Upside Volatility
60 days
+59.88%
Maximum Daily Downside Volatility
60 days
+49.59%
Liquidity
Average Turnover Rate
60 days
+1.30%
120 days
+2.43%
5 years
--
Turnover Deviation
20 days
-79.12%
60 days
-54.10%
120 days
-14.45%
Peer Comparison
Healthcare Equipment & Supplies
Envoy Medical Inc
COCH
5.27 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Lantheus Holdings Inc
LNTH
8.68 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Anika Therapeutics Inc
ANIK
8.58 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
LivaNova PLC
LIVN
8.37 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Thermo Fisher Scientific Inc
TMO
8.35 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Bruker Corp
BRKR
8.23 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
